Amerise Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	5.92	0.22	0.21	0.14	0.13
Cash & Short-Term Investments	5.92	0.22	0.21	0.14	0.13
Cash Growth	2566.22%	5.21%	55.15%	4.61%	-32.69%
Receivables	-	-	-	-	62.17
Other Current Assets	0.2	0.05	0.02	-	-0
Total Current Assets	6.12	0.27	0.23	0.14	62.29
Long-Term Investments	37.7	23.81	22.65	45.66	46.91
Other Long-Term Assets	-	-	-	-	-0
Total Assets	74.22	84.63	53.9	56.47	119.88
Accounts Payable	-	-	-	-	62.66
Current Income Taxes Payable	-	0.02	-	-	-
Other Current Liabilities	20.26	30.82	0.16	0.37	0.01
Total Current Liabilities	20.26	30.84	0.16	0.37	62.67
Long-Term Debt	-	-	-	0.9	0.83
Other Long-Term Liabilities	-	-	-	-	-0
Total Liabilities	20.26	30.84	0.16	1.27	63.49
Common Stock	66.07	66.07	66.07	66.07	66.07
Retained Earnings	-	-13.09	-13.14	-11.68	-10.49
Comprehensive Income & Other	-12.11	0.81	0.81	0.81	0.81
Shareholders' Equity	53.96	53.8	53.74	55.2	56.39
Total Liabilities & Equity	74.22	84.63	53.9	56.47	119.88
Total Debt	-	-	-	0.9	0.83
Net Cash (Debt)	5.92	0.22	0.21	-0.76	-0.7
Net Cash Growth	2566.22%	5.21%	-	-	-
Net Cash Per Share	0.10	0.00	0.00	-0.01	-0.01
Filing Date Shares Outstanding	61.3	66.07	66.07	66.07	66.07
Total Common Shares Outstanding	61.3	66.07	66.07	66.07	66.07
Working Capital	-14.14	-30.57	0.07	-0.23	-0.37
Book Value Per Share	0.88	0.81	0.81	0.84	0.85
Tangible Book Value	53.96	53.8	53.74	55.2	56.39
Tangible Book Value Per Share	0.88	0.81	0.81	0.84	0.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.